Genesis Therapeutics Closes Oversubscribed $200M Series B

Drug Discovery

Unlocking novel protein targets, exploring untapped chemical space, and accelerating the development of critical new medicines with the industry's most advanced molecular AI platform.
Our Company
We’re a tight-knit team of proven drug hunters, deep learning researchers, and software engineers collaborating to drive AI in biochemistry, discovering and developing new therapies for patients suffering from severe disorders.
Learn more ->
Our Platform
A pioneering approach to AI for biotech:
3D spatial graph modeling + cutting-edge molecular simulation to generate novel drug candidates.
Learn more ->